Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Devils Claw is NYAGs Current Supplement Target
Eric Schneiderman’s office said the Harpagophytum zeyheri species of devil’s claw is less desirable than Harpagophytum procumbens. The natural products industry disagrees.
September 17, 2015
The New York Attorney General sent cease-and-desist letters to manufacturers of devil’s Claw supplements, saying DNA barcoding tests revealed that instead of containing the devil’s claw strain Harpagophytum procumbens, it contained the strain Harpagophytum zeyheri.
Schneiderman’s office said the zeyheri species is less desirable. The natural products industry disagrees.
Watch this INSIDER TV news desk to get the industry’s take.
Read more: “New York Attorney General Schneiderman Targets ‘Devil’s Claw’ Supplements”
You May Also Like